// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Assessing the Impact of Minimally Invasive Liver Surgery in the Overweight and Obese: An International Multicenter Propensity Score Matched Analysis

G. Zimmitti - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Do Elderly Patients Undergoing Pancreaticoduodenectomy Benefit from Enhanced Recovery after Surgery?

S.S. Raza - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effect of Diabetes Mellitus on Survival in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis

A. Borakati - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

Genome-wide Association Study Reveals 27 Novel Loci Associated with Gallstone Disease

C.J. Fairfield - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gallbladder disease

N/A

Bile Leakage after Laparoscopic and Open Liver Resection; Incidence and Clinical Impact: An International Multicenter Propensity Score-matched Study of 13,379 Patients

B. Gorgec - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparing Practice and Outcome of Laparoscopic Liver Resection Between High-volume Expert Centres and Nationwide Low-medium Volume Centres

B. Gorgec - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

First Year of the European Registry for Minimally Invasive Pancreatic Surgery (E-MIPS)

N. van der Heijde - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Survival Analysis of Surgical Management of Gallbladder Cancer: Single Center 12-year Experience

M. Alarabiyat - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gallbladder cancer

N/A

Evaluation of the ISGLS Criteria for Post-hepatectomy Liver Failure: Insights from Consideration of the Comprehensive Complication Index as a Measure of Morbidity

L. Calthorpe - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

First Analysis of d-ALPPS, a Safe Alternative to ALPPS

P.D. Kron - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Global Outcomes and Learning Curve for Clinical Outcomes and Proficiency of Robotic Pancreatoduodenectomy

L.R. Jones - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

It is Not the N Status but the Lymph Node Ratio to Determine Survival and Recurrence Patterns in Resected Distal Cholangiocarcinoma

M. Di Martino - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Systemic inflammation

N/A

Organ Space Surgical Site Infections Predict Outcomes Following Pancreato-duodenectomy

I. Shapey - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Para-aortic Lymph Node Involvement Should Not Be a Contraindication to Resection of Pancreatic Ductal Adenocarcinoma

S.A. Chughtai - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

Management of Colorectal Cancer with Synchronous Liver Metastases: The Final Results of the CoSMIC Inception Cohort Study

A. Chan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Potential Utility of Intraoperative Fluid Amylase Measurement during Pancreaticoduodenectomy

K. Joshi - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Robotic versus laparoscopic distal pancreatectomy for upfront resectable pancreatic cancer: An international retrospective cohort study

J.W. Chen - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Textbook Outcome in Laparoscopic and Open Liver Surgery (TOLS): An International Multicenter Analysis of 8188 Patients

B. Gorgec - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Post-liver Transplant Inferior Vena Cava Stenosis in a Large Volume UK Centre

H.V. Spiers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Determination of the Prognostic Utility of Immunohistochemically Assessed hENT1 Expression in Resected Hilar Cholangiocarcinoma Patients

N. Bird - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Klatskin tumors

N/A

Copyright © 2026. QuantiNova All rights reserved